ANTI HCV (ELISA/ECLIA) Test in Chennai

The most common cause of Post transfusion hepatitis is HCV. The HCV antibodies are found after 6 months of the onset of the infection, during the late convalescent stage. The test is used for screening a patient for resolved or chronic HCV.

Test type Blood
Pre-test Information No special preparation is required for the test.
Report Delivery Same Day
Components -
Price ₹ 1650

Info for Doctor

HCV antibodies are usually not detectable during the first 2 months following infection and they are usually detectable by the late convalescent stage (>6 months after onset) of infection. A positive result indicates the presence of hepatitis C virus (HCV)-specific IgG antibodies due to past (resolved) or chronic hepatitis C. Specimens that are repeatedly reactive by screening tests should be confirmed by more HCV-specific tests such as direct detection of HCV RNA by the reverse transcriptase-PCR (RT-PCR) or confirmatory detection of HCV antibodies by serologic assays using recombinant HCV-specific antigens. An indeterminate result indicates that HCV-specific IgG antibodies may or may not be present. Indeterminate results should be interpreted along with patient's risk factors for HCV infection and clinical findings. Individuals at risk for HCV infection with indeterminate results should be retested with an HCV antibody confirmatory test in 1 to 2 months to determine the definitive HCV antibody status.

Not available

HCV antibodies are usually not detectable during the first 2 months following infection and they are usually detectable by the late convalescent stage (>6 months after onset) of infection. A positive result indicates the presence of hepatitis C virus (HCV)-specific IgG antibodies due to past (resolved) or chronic hepatitis C. Specimens that are repeatedly reactive by screening tests should be confirmed by more HCV-specific tests such as direct detection of HCV RNA by the reverse transcriptase-PCR (RT-PCR) or confirmatory detection of HCV antibodies by serologic assays using recombinant HCV-specific antigens. An indeterminate result indicates that HCV-specific IgG antibodies may or may not be present. Indeterminate results should be interpreted along with patient's risk factors for HCV infection and clinical findings. Individuals at risk for HCV infection with indeterminate results should be retested with an HCV antibody confirmatory test in 1 to 2 months to determine the definitive HCV antibody status.